Related Experiment Video
Updated: Nov 16, 2025
11:34
A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
581
Persisting lymphopenia and dimethyl fumarate: A clinical commentary
1Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|February 23, 2021
Abstract:
Severe prolonged lymphopenia as rare side-effect of dimethyl fumarate is mostly reversible. Caldito et al. report a case of persistent severe lymphopenia over 5 years after discontinuation of dimethyl fumarate. We discuss several clinical implications. Safe withdrawal of disease modifying therapies in terms of reoccurrence of disease activity and drug related adverse events need further attention as our treatment armamentarium continues to grow.
